University of California San Francisco
Give to UCSF
Displaying 9841 - 9870 of 16415
-
-
Emergency Rooms Preparing for Busy New Year's Eve
-
Two Men Receive Transplants on Christmas from Oakland Shooting Victim
-
Blindness Breakthrough Seen
-
Repairing Infected Bones
-
ERs Fill with Intoxicated at Year's End
-
Oakland Boy Pays It Forward After Receiving a Liver Transplant
-
Ellen Kelley: Heed Cannabis Science, Not Legal Threats
-
War's Fallout Includes Brain Injuries, Anxiety and Depression
-
Cancer Researchers Win Grants
-
Why Hard Times Can Make Great Buildings
-
Doctors Now Able to Heal Bones that Would Not Heal Before
-
UCSF Cancer-Drug Spinoff Acquired for $190 Million
<p>A cancer drug company founded by UCSF Professor <a href="http://cancer.ucsf.edu/people/shokat_kevan.php">Kevan Shokat</a>, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.</p>
-
Gladstone, Bristol Myers Squibb Strike Alzheimer's Research Deal
-
Just How Good Are the TSA's Body Scanners?
-
Why Heart Attacks May Peak on Christmas
-
If It's Not a War on Cancer, What Is It?
-
New Law to Stop 'Robo-Tripping' Needs a Village to Make It Work
-
Former Reginans Changing the Future of HIV
-
I'm Feeling Healthy
-
Warren Hellman Memorial Celebrates Knack for Life
-
UCSF Biochemist Wins Prestigious Prize
Peter Walter, PhD, a professor in the Biochemistry and Biophysics Department within the School of Medicine at the University of California, San Francisco has been awarded the 2012 Paul Ehrlich and Ludwig Darmstaedter Prize for his “outstanding research achievements in the field of cell biology.”
-
More Potent Ways to Design HIV Drugs Found
-
UCSF Experts Highlight Need for Innovation in Recruiting Participants for Clinical Trials
-
Myths and Realities About the Biological Clock
-
Journal Retracts Key Study Linking Virus To Chronic Fatigue Syndrome
-
Breakthrough in Treatment to Prevent Blindness
A UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective if given every six months versus annually.
-
Pathogenic Landscape of HIV
In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at UCSF has mapped every apparent physical interaction the virus makes with components of the human cells it infects — work that may reveal new ways to design future HIV/AIDS drugs.
-
Cigarette Additives Increase Toxicity: Study
-
President Obama Honors UCSF Internship Program
<p>The UCSF Science & Health Education Partnership High School Internship Program was honored with the Presidential Award for Excellence in Science Mentoring on Dec. 12 at an awards ceremony at the Eisenhower Executive Office Building in Washington, D.C.</p>
